Whittier Trust’s Genelux GNLX Stock Holding History

Whittier Trust’s Portfolio GNLX Stock Details GNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,141	Closed	-$175K	–	1572
2023 Q3	$175K	Buy	+7,141	New	+$181K	﹤0.01%	650

Other funds holding GNLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WDC

Woodward Diversified Capital Bakersfield, California $220M AUM 30.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PWM

Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Whittier Trust's GNLX Position: Q4 2023 in Review

Whittier Trust sold out of Genelux (GNLX) in Q4 2023, closing a stake of 7,141 shares — an estimated $175K sold.

Whittier Trust first reported a position in GNLX in Q3 2023 and held it in 1 quarter. The position peaked at $175K in Q3 2023. 61 funds tracked by Wall St. Rank hold GNLX as of Q4 2023.

Whittier Trust reported no remaining Genelux position as of Q4 2023 after selling out during the quarter.
Whittier Trust sold 7,141 Genelux shares in Q4 2023, an estimated $175K.
Whittier Trust first reported a position in Genelux in Q3 2023 and held it in 1 quarter.
Whittier Trust's Genelux position peaked at $175K in Q3 2023.
61 funds tracked by Wall St. Rank held Genelux as of Q4 2023.

Based on Whittier Trust's 13F filing for Q4 2023, filed 11 Jan 2024.